Dr Anand Velusamy, Consultant Endocrinologist

Dr Anand Velusamy

Consultant Endocrinologist

Book online
|

Dr Anand Velusamy MBBS

Consultant Endocrinologist

MBBS

Dr Anand Velusamy

Consultant Endocrinologist MBBS

Book online
|
MBBS
HCA-Healthcare-UK

Areas of expertise

  • Adrenocorticotropin stimulation tests (ACTH)
  • Blood glucose monitoring
  • Dexamethasone suppression test
  • Fine needle thyroid biopsy
  • Pituitary function test
HCA-Healthcare-UK

Address

  • HCA UK at The Shard

    St Thomas Street, London, SE1 9BS

  • HCA UK City of London

    120 Old Broad Street, London, EC2N 1AR

  • London Bridge Hospital

    27 Tooley Street, London, SE1 2PR

About Dr Anand Velusamy

GMC number: 6050815

Year qualified: 2000

Place of primary qualification: Tamil Nadu Dr MGR Med University

Dr Anand Velusamy is a Consultant Endocrinologist at Guy's and St. Thomas' Hospital, with a private practice at HCA London Bridge/Shard. He specialises in a wide range of endocrine disorders, including thyroid conditions such as overactive and underactive thyroid, goitre, thyroid nodules, and thyroid cancer. Dr Velusamy also has expertise in adrenal and pituitary disorders, bone health and calcium imbalances, and male and female reproductive pathologies, including hypogonadism, erectile dysfunction, amenorrhoea, and PCOS.

In addition to his work with thyroid and reproductive issues, Dr Velusamy is skilled in managing neuroendocrine tumours, hypertension, metabolic syndrome, and weight management. He is also proficient in treating type 2 diabetes and its complications, having presented his research at the annual American Diabetes Conference.

Dr Velusamy graduated with an MBBS in 2002 and completed his specialist training in Endocrinology, Diabetes, and General Internal Medicine at the London Deanery in 2015. He is a Member of the Royal College of Physicians (MRCP UK) and holds professional memberships with the British, European, and American Endocrine Societies, where he regularly contributes his specialist work.

As part of the Southeast London Thyroid Cancer Network, Dr Velusamy is actively involved in the latest advancements in thyroid cancer treatment. He has several publications in peer-reviewed scientific journals, showcasing his clinical and research expertise.

Dr Velusamy's commitment to his field and his patients is evident in his comprehensive approach to endocrine health, making him a leading specialist in his area.

Areas of expertise

  • Acromegaly or gigantism
  • Addison's disease
  • Adrenal disease
  • Adrenocorticotropin stimulation tests (ACTH)
  • Blood glucose monitoring
  • Cushing's syndrome
  • Dexamethasone suppression test
  • Diabetes insipidus
  • Disorders of bone metabolism
  • Endocrine hypertension
  • Fine needle thyroid biopsy
  • General medicine
  • Goitre
  • Graves' disease
  • Hashimoto's thyroiditis
  • Hormone disorders (male)
  • Hormone imbalances and disorders (female)
  • Hypertension (high blood pressure)
  • Hyperthyroidism
  • Low blood pressure
  • Menopause
  • Metabolic syndrome
  • Osteoporosis
  • Parathyroid disease
  • Pituitary disorders
  • Pituitary function test
  • Polycystic ovary syndrome (PCOS)
  • Prolactinoma
  • Pulmonary embolism (lung blood clot)
  • Reproductive disorders
  • Synacthen test
  • Thyroid nodules
  • Thyroid problems
  • Tiredness (fatigue)
  • Type 2 diabetes
  • Variable blood pressure
  • Vitamin D deficiency

Professional memberships

Royal College of Physicians
Society for Endocrinology (UK)
European Society of Endocrinology
Endocrine Society (US)
UK and Ireland Neuroendocrine Tumour Society
General Medical Council

Articles by Dr Anand Velusamy

Bladder paragangliomas

Imaging features of succinate dehydrogenase-deficient pheochromocytoma-paraganglioma syndromes

Investigating the role of somatic sequencing platforms for phaeochromocytoma and paraganglioma in a large UK cohort

Tumour detection and outcomes of surveillance screening in SDHB and SDHD pathogenic variant carriers

SDHC phaeochromocytoma and paraganglioma

Genetic testing for hereditary hyperparathyroidism and familial hypocalciuric hypercalcaemia in a large UK cohort

What is the best way of assessing neurocognitive dysfunction in patients with primary hyperparathyroidism?

Postradioiodine graves' management

When to suspect 'funny' diabetes

Other specialists recommended by Dr Velusamy